跳至主要内容
临床试验/EUCTR2018-004287-56-FR
EUCTR2018-004287-56-FR进行中(未招募)1 期

Randomized placebo-controlled trial comparing Methotrexate vs. Methotrexate/Metformin association in rheumatoid arthritis patients: METorMET² study - METorMET2

CHU de Bordeaux0 个研究点目标入组 128 人开始时间: 2020年1月31日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patients aged over 18 years old,
  • - Patient affected by RA according to ACR 2010 criteria
  • - DAS28 > 3.2
  • - Methotrexate naïve patients, or without any methotrexate intake for more than six months.
  • - Men who accept to take active contraception during the study and during six months after the end of the Methotrexate treatment. Partner of patient will be informed of teratogenicity of MTX and will be advised to be on effective contraceptives for all the study duration.
  • - Women with a negative test of ß-HCG who accept to take active contraception during the study and during six months after the end of the Methotrexate treatment
  • - Patients without any Metformin previous therapy.
  • - Being affiliated to a health insurance system
  • - Having signed an informed consent form (later than the day of inclusion and before any examination required by the research)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 108
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • - Patient who present contraindications to treatment with Methotrexate or Metformin
  • - Patient with daily corticosteroid treatment at a dosage = 15 mg/day within four weeks before the inclusion
  • - History of allergy or intolerance to biguanide
  • - Renal insufficiency with clearance < 60 ml/mn
  • - Decompensated heart failure
  • - Coronary insufficiency
  • - Severe respiratory insufficiency
  • - Hepatic insufficiency
  • - Acute infection
  • - Critical ischemia of the lower limbs
  • - Recent stroke
  • - B12 Vitamin deficiency
  • - Patient performing or planning to perform a long-fasting period
  • - Pregnant or breastfeeding women
  • - Patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).

研究者

发起方
CHU de Bordeaux

相似试验